Continuous Positive Airway Pressure (CPAP) Devices Market by Product (CPAP Devices, CPAP Humidifier and CPAP Masks)
Industry: Healthcare
Published Date: March-2023
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 250
Report ID: PMRREP31515
The Global revenue from the Continuous Positive Airway Pressure (CPAP) Devices Market was US$ 3.5 Billion in 2022, with the global market expected to grow at a CAGR of 6.0% to reach a valuation of approximately US$ 6.7 Billion by the end of 2033.
|
Market Size (2023) |
US$ 3.7 Billion |
|
Projected Market Value (2033) |
US$ 6.7 Billion |
|
Global Market Growth Rate (2023 to 2033) |
6.0% CAGR |
|
Market Share of Top 5 Countries |
58.0% |
As assessed by Persistence Market Research, the product segment CPAP devices held a prominent market share of 51.3% in the global market, in 2022. Overall, continuous positive airway pressure (CPAP) devices market sales account for 46.7% of revenue share in the global sleep apnea devices market, which was valued at around US$ 7.6 Billion in 2022.
The global market recorded a historic CAGR of 5.6% in the last 7 years from 2015 to 2022.
Oxygen is an important requirement for people suffering from respiratory disorders. Most respiratory disorders are chronic in nature and their treatment requires a constant demand for drugs and other necessary services like hospital ventilators. People in high-income countries are more susceptible to suffering from chronic obstructive pulmonary disease (COPD) due to high levels of pollution and rapid lifestyle changes. The WHO also noted that mortality due to chronic obstructive pulmonary disease is likely to increase in the coming years due to ageing populations and higher smoking prevalence in newly developing countries.
The CPAP industry is getting a burst of desperate orders from China, Italy, Germany and the United States for the management of patients with severe respiratory illnesses. During COVID-19 pandemic, the FDA issued a wide-ranging emergency policy allowing alternative devices such as CPAP to be used as potentially life-saving ventilators.
Therefore, the manufacturers are also focusing on boosting up their ventilator manufacturing capacity. For instance, companies such as Medtronic, Koninklijke Philips N.V., and Resmed planned to expand their CPAP production by more than 40%-to supply CPAP in response to the urgent needs across the globe confronting COVID-19.
The global market is likely to show high growth over the coming years at a CAGR of 6.0% and reach a global market size of US$ 6.7 Billion by 2033.
“Rising prevalence of chronic respiratory diseases”
One of the main causes of illness and mortality globally, chronic respiratory disorders (CRDs) affect the airways and other lung components. Asthma, chronic obstructive pulmonary disease (COPD), occupational lung disorders and lung cancer are a few of the most prevalent chronic respiratory illnesses. According to WHO, in 2019, globally 3.23 million deaths were caused due to chronic obstructive pulmonary disease (COPD).
The worldwide patient pool for coronavirus disease (Covid-19) pandemic has positively impacted the market. According to WHO, globally as of 21 February 2023, there have been 757,264,511 confirmed cases of COVID-19 including 6,850,594 deaths. The death rate is more often found in the geriatric population. The growing incidence of coronavirus disease increased the demand for medicines as well as medical ventilators.
As a result, the manufacturers of medical CPAP and governments have adopted drastic measures to produce more numbers of CPAP, thereby increasing the sales of CPAP devices.
“Availability of Alternative Treatment for Sleep Apnea”
One of the most common respiratory disorders associated with sleep is OSA. For the treatment of obstructive sleep apnea (OSA), oral appliances have become a viable alternative to continuous positive airway pressure (CPAP).
A mandibular advancing device, also known as a mandibular repositioning appliance, is the most popular type of oral treatment for sleep apnea. Therefore, it is anticipated that demand for alternative treatment choices may impede the market's expansion for continuous positive air pressure devices.
There is a notion that snoring or being sleepy is natural, people do not correlate sleep apnea with its numerous dangerous comorbidities, such as increased incidence of cardiovascular disease, diabetes, and accidents, and the general population is unaware of the health risks associated with OSA. Hence, a large proportion of OSA is undiagnosed despite the technological advancements in the diagnosis.
Thus, the availability of alternative treatments and negligence by people to avoid using devices may hamper the growth of the market in the forecasted period.
Why is the United States Market Booming?
“Rise in regulatory approvals”
The United States accounted for 34.0% market share in the global market in 2022.
With the increasing acceptance rate of sleep services brought on by the high obesity incidence and erratic lifestyles, North America is predicted to be the leading market for continuous positive airway pressure devices globally. The major market players in the region are upgrading their products and launching into the market. For instance, In April 2017, Resmed Inc. launched AirMini, the smallest portable CPAP into the market.
The market for continuous positive airway pressure devices in North America is more lucrative than markets in other regions due to the development of new devices and their regulatory approvals by the government.
Will the United Kingdom Be a Lucrative Market for Continuous Positive Airway Pressure (CPAP) Devices?
“Increasing healthcare spending and improving healthcare expenditure”
The United Kingdom market held around 5.3% market share of the global market in 2022.
Innovative therapies need to be encouraged right away in order to address the enormous social and financial burden that treatment-resistant mental health issues cause in the United Kingdom The installation and use of advanced medical gadgets in healthcare facilities like hospitals are supported by improved healthcare infrastructure and increased medical spending by the relevant governments. This results in a rise in CPAP demand in the market.
How is China Emerging as a Prominent Market?
“Rise in geriatric population and obstructive sleep apnea disease”
China held a market share of about 6.7% of the global market in 2022. One of the world's fastest-growing ageing populations is in China. According to WHO, due to rising life expectancy and falling birth rates, 28% of China's population is expected to be over 60 by 2040. According to the International Journal of Chronic Obstructive Pulmonary Disease, 13.7% of the population in China is projected to have COPD, which translates to 99.9 million individuals. COPD will continue to be a major source of illness and mortality with considerable economic and social burden implications on public health because of rising life expectancy and lifestyle changes.
As a result, with the increasing life expectancy and prevalence of COPD, the demand for continuous positive airway pressure devices also increases.
Which Product is Driving Demand within the Global Market?
“Enhancement and Creating Compact and Secure Products”
The CPAP devices product segment held a share of 51.3% in the total global market in 2022.
A continuous positive airway pressure (CPAP) machine as a product segment is leading because it is one of the most widely used forms of treatment for sleep apnea. It works by keeping the patient's airways open while they sleep so they can receive oxygen for optimal function, which can greatly enhance their sleep and lower their risk of developing a number of health problems.
Which Application is Widely in Focus in the Global Market?
“Benefits of CPAP Devices in Treating OSA”
When the upper airway is partially or completely blocked while sleeping, this is considered obstructive sleep apnea. Opening the airway and bringing air into the lungs requires more effort from the diaphragm and chest muscles. It might even cause short-stop breathing if regular breathing becomes extremely shallow. A loud gasp, snort, or body jerk typically signals the beginning of a new breath.
The breathing pauses brought on by sleep apnea are avoided using CPAP devices. In addition, these devices also get rid of the negative symptoms of sleep apnea. Increased quality of sleep, reduced risk of stroke and heart attack, and decrease in tiredness are some of the benefits of CPAP devices. These benefits of CPAP devices in treating obstructive sleep apnea is responsible for segment growth.
Which End User Propels the Global Sales in the Market?
“Hospital to Serve Large Patient Pool”
The hospital by end user held a share of 54.5% in 2022, within the global market.
A prominent factor driving the hospital segment is the vast patient pool of people who suffer from chronic diseases that include COPD, asthma and sleep disorders that hospitals around the world treat. Due to the rising number of private hospitals and the advantageous reimbursement rules, the hospital segment holds a prominent share of the global market.
Companies in the industry are placing a strong emphasis on providing a wide range of continuous positive airway pressure (CPAP) devices and on their involvement in the development of new technologies. The company's channel strategy calls for expanding its direct sales team and independent distributors in the US as well as other countries around the world to provide consistent performance and product reach to customers.
Some key instances of development include:
Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the continuous positive airway pressure (CPAP) devices market, which are available in the full report.
|
Attribute |
Details |
|
Forecast Period |
2023 to 2033 |
|
Historical Data Available for |
2015 to 2022 |
|
Market Analysis |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Covered |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon Request |
Product:
Application:
End User:
Region:
To know more about delivery timeline for this report Contact Sales
The global market is currently valued at around US$ 3.5 Billion in 2022.
Sales of the market are set to witness growth at a CAGR of 6.0% and be valued at around US$ 6.7 Billion by 2033.
Demand for the global market increased at a 5.6% CAGR from 2015 to 2022.
The U.S., China, France, the U.K., and Germany account for most demand within the market, currently holding around 58.0% market share.
The U.S. accounts for around 34.0% share of the global market in 2022.
North America accounts for a share of 37.0% of the global market in 2022.
The Europe market held a share of 28.3% in the global continuous positive airway pressure (CPAP) devices market in 2022.
The German continuous positive airway pressure (CPAP) devices market holds a share of 7.5% in 2022.
The China continuous positive airway pressure (CPAP) devices market holds a share of 6.7% in the global market in 2022.
The continuous positive airway pressure (CPAP) devices market in East Asia holds a share of 13.6% in 2022.
